NO20050915L - Flerkomponent farmasoytisk doseringsform - Google Patents

Flerkomponent farmasoytisk doseringsform

Info

Publication number
NO20050915L
NO20050915L NO20050915A NO20050915A NO20050915L NO 20050915 L NO20050915 L NO 20050915L NO 20050915 A NO20050915 A NO 20050915A NO 20050915 A NO20050915 A NO 20050915A NO 20050915 L NO20050915 L NO 20050915L
Authority
NO
Norway
Prior art keywords
dosage form
pharmaceutical dosage
component pharmaceutical
eudragit
aperture
Prior art date
Application number
NO20050915A
Other languages
English (en)
Norwegian (no)
Inventor
Michael Birsha Davies
Paul Kenneth Rand
Stanley George Bonney
Stephen Mark Mcallister
Adrian Brown
Wayne M Matthews
Daniel N Margetson
Alan Anthony Wilson
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0217336A external-priority patent/GB0217336D0/en
Priority claimed from GB0302435A external-priority patent/GB0302435D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO20050915L publication Critical patent/NO20050915L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61JCONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/07Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
    • A61J3/071Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use into the form of telescopically engaged two-piece capsules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20050915A 2002-07-25 2005-02-21 Flerkomponent farmasoytisk doseringsform NO20050915L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0217336A GB0217336D0 (en) 2002-07-25 2002-07-25 Multicomponent pharmaceutical dosage form
GB0302435A GB0302435D0 (en) 2003-02-03 2003-02-03 Pharmaceutical formulation
PCT/GB2003/003157 WO2004010978A1 (en) 2002-07-25 2003-07-24 Multicomponent pharmaceutical dosage form

Publications (1)

Publication Number Publication Date
NO20050915L true NO20050915L (no) 2005-04-14

Family

ID=31189604

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20050915A NO20050915L (no) 2002-07-25 2005-02-21 Flerkomponent farmasoytisk doseringsform

Country Status (19)

Country Link
US (1) US20060057201A1 (pl)
EP (2) EP2556825A1 (pl)
JP (1) JP4617256B2 (pl)
KR (2) KR101178352B1 (pl)
CN (1) CN100553621C (pl)
AR (1) AR040672A1 (pl)
AU (1) AU2003281758B2 (pl)
BR (1) BR0312887A (pl)
CA (1) CA2493983C (pl)
IL (1) IL166286A0 (pl)
IS (1) IS7689A (pl)
MX (1) MXPA05000948A (pl)
MY (1) MY142179A (pl)
NO (1) NO20050915L (pl)
NZ (1) NZ537682A (pl)
PL (2) PL400027A1 (pl)
RU (1) RU2325153C2 (pl)
TW (1) TWI336260B (pl)
WO (1) WO2004010978A1 (pl)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0012869A (pt) 1999-07-30 2002-05-21 Smithkline Beecham Plc Forma de dosagem farmacêutica de componentes múltiplos
US7883721B2 (en) 2001-01-30 2011-02-08 Smithkline Beecham Limited Pharmaceutical formulation
US7842308B2 (en) * 2001-01-30 2010-11-30 Smithkline Beecham Limited Pharmaceutical formulation
US20050175687A1 (en) * 2001-01-30 2005-08-11 Mcallister Stephen M. Pharmaceutical formulations
GB0102342D0 (en) * 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
US7670612B2 (en) * 2002-04-10 2010-03-02 Innercap Technologies, Inc. Multi-phase, multi-compartment capsular delivery apparatus and methods for using same
TW200526274A (en) * 2003-07-21 2005-08-16 Smithkline Beecham Plc Pharmaceutical formulations
PE20060003A1 (es) * 2004-03-12 2006-03-01 Smithkline Beecham Plc Formulacion farmaceutica polimerica para moldear por inyeccion
EP1836665B1 (en) 2004-11-19 2013-01-16 GlaxoSmithKline LLC Method for customized dispensing of variable dose drug combination products for individualizing of therapies
WO2009023006A2 (en) * 2006-05-08 2009-02-19 Mcneil-Ppc, Inc. Modified release dosage form
SI3095447T1 (sl) 2006-02-03 2022-02-28 Opko Renal, Llc Zdravljenje pomanjkanja vitamina D s 25-hidroksivitaminom D2 in 25-hidroksivitaminom D3
HUE037309T2 (hu) 2006-06-21 2018-08-28 Opko Ireland Global Holdings Ltd Terápia D-vitamin telítési szer alkalmazásával és D-vitamin hormon helyettesítõ szer
US20100074926A1 (en) * 2006-12-05 2010-03-25 Universita' Degli Studi Di Parma Modules, new assemblage kits and new assembles for the controlled release of substances
DK2148684T3 (da) 2007-04-25 2013-04-22 Cytochroma Inc Fremgangsmåde til behandling af vitamin D-insufficiens og -deficiens
PL2148661T3 (pl) 2007-04-25 2013-07-31 Cytochroma Inc Doustne kompozycje o kontrolowanym uwalnianiu zawierające związek będący witaminą D i woskowy nośnik
DE102007023399A1 (de) * 2007-05-22 2008-11-27 Robert Bosch Gmbh Kapsel zur Aufnahme eines Mediums sowie Verfahren zur Herstellung einer derartigen Kapsel
JP2011500185A (ja) 2007-10-15 2011-01-06 グラクソ グループ リミテッド 1または複数の医薬組成物を放出するためのマルチパート剤形用リンカー、およびその得られた剤形
EP2209467A2 (en) * 2007-10-15 2010-07-28 Glaxo Group Limited Multipart capsule for staged release of one or more substances
US8293159B2 (en) * 2007-10-15 2012-10-23 Capsugel Belgium Method and apparatus for manufacturing filled linkers
US8454992B2 (en) 2007-10-15 2013-06-04 Capsugel Belgium Nv Paneled capsule shells for release of pharmaceutical compositions
JP2011503048A (ja) 2007-11-08 2011-01-27 グラクソ グループ リミテッド 医薬製剤
US20110027356A1 (en) * 2008-01-25 2011-02-03 Duo-Ge Combination of Oral Medicaments Bonded by a Wrapping
WO2009150228A2 (en) * 2008-06-13 2009-12-17 Glaxo Group Limited Pharmaceutical formulations
US20100233258A1 (en) * 2009-03-13 2010-09-16 Inovista Inc. Tablet having concavity with active ingredient disposed therein and manufacturing method thereof
PT2552484T (pt) 2010-03-29 2020-04-03 Opko Ireland Global Holdings Ltd Métodos e composições para redução dos níveis de parafróides
FR2962647B1 (fr) * 2010-07-19 2013-05-24 Duo Ge Dispositif et installation d'assemblage d'au moins deux capsules medicamenteuses par collage
CN103099738B (zh) * 2013-03-06 2014-07-09 史凤阳 一种膜-芯型控释制剂的包覆挤出工艺
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 d 방출 제형
WO2015191922A1 (en) 2014-06-11 2015-12-17 Massachusetts Institute Of Technology Enteric elastomers
US20170266112A1 (en) 2014-06-11 2017-09-21 Massachusetts Institute Of Technology Residence structures and related methods
US10220047B2 (en) * 2014-08-07 2019-03-05 Opko Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
EA201790332A1 (ru) * 2014-08-07 2017-06-30 Опко Айэлэнд Глобал Холдингз Лтд. Дополнительная терапия 25-гидроксивитамином d
US10653622B1 (en) 2015-04-13 2020-05-19 Pharmacoustics Technologies LLC Individualized solid dosage products and a system and method for the globally integrated pharmaceutical manufacturing and its monitoring thereof
HK1258050A1 (zh) 2015-10-23 2019-11-01 Lyndra Therapeutics, Inc. 用於治疗剂缓释的胃驻留系统及其使用方法
EP3386488B1 (en) 2015-12-08 2023-09-06 Lyndra Therapeutics, Inc. Geometric configurations for gastric residence systems
JP6878417B2 (ja) * 2016-02-17 2021-05-26 トリアステック インコーポレイテッド 剤形およびそれらの使用
MY198547A (en) 2016-03-28 2023-09-04 Opko Ireland Global Holdings Ltd Methods of vitamin d treatment
CA3023278C (en) * 2016-05-05 2019-04-30 Triastek, Inc. Controlled release dosage form
AU2017268840B2 (en) 2016-05-27 2022-02-10 Nortiva Bio, Inc. Materials architecture for gastric residence systems
US10456975B2 (en) 2016-07-15 2019-10-29 Multiply Labs Inc. Multi-compartment capsule
WO2018030956A1 (en) * 2016-08-08 2018-02-15 Structo Pte Ltd A 3d printed article, method of use and method of manufacture
US11576866B2 (en) 2016-09-30 2023-02-14 Lyndra Therapeutics, Inc. Gastric residence systems for sustained delivery of adamantane-class drugs
US12023406B2 (en) 2017-06-09 2024-07-02 Lyndra Therapeutics, Inc. Gastric residence systems with release rate-modulating films
NZ760633A (en) * 2017-07-10 2025-11-28 Gel Cap Tech Llc Dual release dosage form capsule and methods, devices and systems for making same
JP7198205B2 (ja) 2017-07-11 2022-12-28 クオリカプス株式会社 腸溶性硬質カプセル
BR112020026058A2 (pt) 2018-06-22 2021-04-13 Qualicaps Co., Ltd. Cápsula entérica dura
HRPK20190905B3 (hr) * 2019-05-16 2022-03-04 Anna POROPAT Sustav doziranja putem dozirnih opni za kontrolirano otpuštanje tvari iz spremnika
TW202233162A (zh) * 2020-10-30 2022-09-01 大陸商南京三迭紀醫藥科技有限公司 胃滯留藥物劑型
CN120168425A (zh) * 2025-05-22 2025-06-20 环信生物科技(泰州)有限公司 一种用于口服递送mRNA的胶囊及其制备方法和应用

Family Cites Families (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US493518A (en) * 1893-03-14 Reel attachment
US260814A (en) * 1882-07-11 Combined seeder and cultivator
US57201A (en) * 1866-08-14 Improvement in braiding-machines
US108492A (en) * 1870-10-18 Improvement in rufflers for sewing-machines
US148518A (en) * 1874-03-10 Improvement in mail-bag holders
US148514A (en) * 1874-03-10 Improvement in band-pulleys
US119597A (en) * 1871-10-03 Improvement in surface-blows for steam-boilers
US74947A (en) * 1868-02-25 Improved meat-cuttek
US177496A (en) * 1876-05-16 gafney
US249807A (en) * 1881-11-22 Dish-handle
US110723A (en) * 1871-01-03 Improvement in car-replacers
US110721A (en) * 1871-01-03 Meat-cutters
US285837A (en) * 1883-10-02 Pocket hand-stamp
US481456A (en) * 1892-08-23 Potato-planter
FR28646E (pl) 1923-04-27 1925-03-17
US3048526A (en) * 1958-08-04 1962-08-07 Wander Company Medicinal tablet
US3186910A (en) * 1962-03-08 1965-06-01 Jacob A Glassman Method for producing peroral capsules
US3228789A (en) 1962-10-22 1966-01-11 Jacob A Glassman Peroral capsules and tablets and the method for making same
NL7610038A (en) 1976-09-09 1978-03-13 Tapanahony N V Multichambered capsule for therapeutically active substances - has chambers of different solubility with contents differing quantitatively and qualitatively
US4281763A (en) * 1979-10-31 1981-08-04 Pace Joseph A Two-piece hardshell, soluble and digestible liquid containing gelatin capsule
US4324338A (en) * 1979-12-27 1982-04-13 Robert Beall Compartmented container
US4316541A (en) * 1980-03-31 1982-02-23 Medi-Dose, Inc. Moisture impervious cover sheet for unit dose packaging
US4655840A (en) 1982-03-26 1987-04-07 Warner-Lambert Company Hydrophilic polymer compositions for injection molding
US4790881A (en) 1982-03-26 1988-12-13 Warner-Lambert Company Molded hydrophilic polymer
EG16028A (en) 1982-03-26 1986-12-30 Warner Lambert Co Apparatus and method for molding capsules
FR2524311A1 (fr) 1982-04-05 1983-10-07 Azalbert Gilles Gelule compartimentee aux fins d'ingestions simultanees a effets differes
US4564363A (en) * 1983-07-13 1986-01-14 Smithkline Beckman Corporation Delayed action assembly
US4576284A (en) 1983-12-02 1986-03-18 Warner-Lambert Company Closing of filled capsules
US4738724A (en) 1983-11-04 1988-04-19 Warner-Lambert Company Method for forming pharmaceutical capsules from starch compositions
CH661878A5 (de) 1983-11-04 1987-08-31 Warner Lambert Co Kapsel-dosierungsformen.
US4738817A (en) 1983-11-17 1988-04-19 Warner-Lambert Company Method for forming pharmaceutical capsules from hydrophilic polymers
US4936461A (en) * 1986-09-18 1990-06-26 Makiej Jr Walter J Multidose capsules
US4793493A (en) * 1986-09-18 1988-12-27 Makiej Jr Walter J Multidose capsules
US5074426A (en) * 1986-11-13 1991-12-24 Warner-Lambert Company Dividable capsule
KR890003520Y1 (ko) * 1986-12-20 1989-05-27 주식회사 서흥캅셀 의약용 캅셀
US5391381A (en) * 1987-06-25 1995-02-21 Alza Corporation Dispenser capable of delivering plurality of drug units
DE3727894A1 (de) 1987-08-21 1989-03-02 Stephan Dieter Kapsel fuer pharmazeutisch wirksame inhaltsstoffe einer droge
FI906328A7 (fi) 1989-04-21 1990-12-20 Moskovsky Avtomobilestroitelny Inst Laite aktiivisten aineiden jakamiseksi ohjatusti toiminnalliseen ympär istöön
US5443459A (en) * 1991-01-30 1995-08-22 Alza Corporation Osmotic device for delayed delivery of agent
US5417682A (en) * 1991-01-30 1995-05-23 Alza Corporation Device for administering active agent to biological environment
US5976571A (en) * 1991-01-31 1999-11-02 Port Systems, L.L.C. Method for making a multi-stage drug delivery system
US5387421A (en) * 1991-01-31 1995-02-07 Tsrl, Inc. Multi stage drug delivery system
US5674530A (en) * 1991-01-31 1997-10-07 Port Systems, L.L.C. Method for making a multi-stage drug delivery system
GB9223144D0 (en) * 1992-11-05 1992-12-16 Scherer Corp R P Controlled release device
GB9223172D0 (en) * 1992-11-05 1992-12-16 Scherer Corp R P Capsule construction
WO1996010996A1 (en) 1993-07-21 1996-04-18 The University Of Kentucky Research Foundation A multicompartment hard capsule with control release properties
US5443461A (en) 1993-08-31 1995-08-22 Alza Corporation Segmented device for simultaneous delivery of multiple beneficial agents
EP0995447A1 (en) * 1993-09-09 2000-04-26 Takeda Chemical Industries, Ltd. Formulation comprising antibacterial substance and antiulcer substance
GB9325445D0 (en) 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
DE9414065U1 (de) 1994-08-31 1994-11-03 Röhm GmbH & Co. KG, 64293 Darmstadt Thermoplastischer Kunststoff für darmsaftlösliche Arznei-Umhüllungen
RU2114599C1 (ru) * 1996-04-16 1998-07-10 Акционерное общество открытого типа Завод "Компонент" Капсула для перорального введения с управляемым выделением лекарственного вещества
EP1053752A1 (en) * 1998-02-10 2000-11-22 Yoshitomi Pharmaceutical Industries, Ltd. Preparations with controlled release
BR0012869A (pt) 1999-07-30 2002-05-21 Smithkline Beecham Plc Forma de dosagem farmacêutica de componentes múltiplos
CN1210190C (zh) * 1999-11-17 2005-07-13 水溶胶有限公司 注模形成的水溶性容器
DE19958007A1 (de) 1999-12-02 2001-06-07 Roehm Gmbh Spritzgußverfahren für (Meth)acrylat-Copolymere mit teritiären Ammoniumgruppen
DE19961334A1 (de) 1999-12-17 2001-06-21 Roehm Gmbh Spritzgußverfahren für neutrale und säuregruppenhaltige (Meth)acrylat-Copolymere
US7883721B2 (en) * 2001-01-30 2011-02-08 Smithkline Beecham Limited Pharmaceutical formulation
GB0102342D0 (en) 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
US7842308B2 (en) * 2001-01-30 2010-11-30 Smithkline Beecham Limited Pharmaceutical formulation
CA2448997A1 (en) * 2001-05-31 2002-12-05 Microdose Technologies, Inc. Metering and packaging of controlled release medication
PE20060003A1 (es) * 2004-03-12 2006-03-01 Smithkline Beecham Plc Formulacion farmaceutica polimerica para moldear por inyeccion
TW200845991A (en) * 2007-01-12 2008-12-01 Smithkline Beecham Corp N-substituted glycine derivatives: hydroxylase inhibitors
JP2011503048A (ja) * 2007-11-08 2011-01-27 グラクソ グループ リミテッド 医薬製剤

Also Published As

Publication number Publication date
RU2325153C2 (ru) 2008-05-27
CA2493983A1 (en) 2004-02-05
EP2556825A1 (en) 2013-02-13
KR20050026511A (ko) 2005-03-15
US20060057201A1 (en) 2006-03-16
IL166286A0 (en) 2006-01-15
NZ537682A (en) 2008-11-28
AU2003281758A1 (en) 2004-02-16
CA2493983C (en) 2011-11-08
KR101178352B1 (ko) 2012-08-29
BR0312887A (pt) 2005-06-14
EP1528916A1 (en) 2005-05-11
JP2005538189A (ja) 2005-12-15
PL214288B1 (pl) 2013-07-31
IS7689A (is) 2005-02-08
AR040672A1 (es) 2005-04-13
CN1678294A (zh) 2005-10-05
PL400027A1 (pl) 2012-10-22
EP1528916B1 (en) 2012-12-26
KR20110046587A (ko) 2011-05-04
TW200413030A (en) 2004-08-01
CN100553621C (zh) 2009-10-28
TWI336260B (en) 2011-01-21
MXPA05000948A (es) 2005-05-16
PL374867A1 (pl) 2005-11-14
AU2003281758B2 (en) 2007-10-04
MY142179A (en) 2010-10-15
JP4617256B2 (ja) 2011-01-19
WO2004010978A1 (en) 2004-02-05
RU2005105061A (ru) 2005-08-10

Similar Documents

Publication Publication Date Title
NO20050915L (no) Flerkomponent farmasoytisk doseringsform
RU2764576C2 (ru) Составы (r)-2-амино-3-фенилпропилкарбамата
Lehotský et al. Ischemic tolerance: the mechanisms of neuroprotective strategy
CA2338780A1 (en) Preparation capable of releasing medicinal substance at targeted site in intestine
WO2004066912A3 (en) Anti-inflammatory compositions and uses thereof
ES2126536A1 (es) "preparado farmaceutico para administracion intranasal"y procedimiento para su produccion.
MY169471A (en) Controlled release preparation
AR048331A1 (es) Sistema de administracion de farmacos con retencion gastrica
NO20062040L (no) Modulatorer for atp-bindende kassett-transportere inneholdende cykloalkyl eller pyranylgrupper
NO953781L (no) Terapeutisk anvendelse av keratinocyttvekstfaktor
BR0107564A (pt) Composição de gliburida
ATE344022T1 (de) Proinsulin c-peptid enthaltende arzneizubereitung mit verzögerter wirkstofffreigabe
BRPI0514682A (pt) composição de liberação rápida incluindo gránulos de derretimento de um medicamento sensìvel à umidade e processos para manufatura deste
NO20071315L (no) Farmasoytisk preparat i form av en tablett inneholdende et aktivt prinsipp for opphold i magen.
Paral et al. Glued versus stapled anastomosis of the colon: an experimental study to determine comparative resistance to intraluminal pressure
ATE478662T1 (de) Arzneilösungen enthaltend modafinilverbindungen
NO20073176L (no) Nye medikamenter for behandling av luftveissykdommer
ATE104146T1 (de) Zubereitung mit verzoegerter freigabe eines hydrochlorids eines basischen arzneistoffs.
WO2004062552A3 (en) Pharmaceutical composition containing a nsaid and a benzimidazole derivative
WO2001088533A3 (en) Lipid uptake assays
EP1961819A3 (en) Composition and methods for the therapy and diagnosis of lung cancer
Sandeep et al. Design and development of chronopharmaceutical drug delivery of lansoprazole
Lightowler et al. Comparative mucolytic studies on dithiothreitol, N-acetyl-cysteine and L-cysteine on human respiratory mucus in vitro and their effects on the rate of flow of mucus in the exposed trachea of the rat on topical application
FI20050297A7 (fi) Gelatiinittomat kalvot, joilla on parannetut sulkuominaisuudet
BRPI0507765A (pt) comprimidos revestidos compressos e sua produção

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application